The effectiveness of bevacizumab (Avastin) and related trials

Real-world use of bevacizumab in patients with breast cancerПодробнее

Is Evidence-Based Medicine a Barrier to Cost-Effective Care?Подробнее

Bevacizumab and cetuximab (plus chemotherapy) equally effective for colorectal cancer patientsПодробнее

Assessing the Use of BevacizumabПодробнее

Dr. Brufsky Discusses Bevacizumab Benefits in TNBCПодробнее

Study Finds Bevacizumab Prolongs Life Among Patients With Deadly Brain CancerПодробнее

Dr Andrew Clamp: Advances in targeted treatment for ovarian cancerПодробнее

BEAT-SC: Phase III trial of bevacizumab or placebo with atezolizumab & chemo in extensive-stage SCLCПодробнее

Super Selective Intra-arterial Infusion for Brain TumorsПодробнее

Safety Findings of Long-Term Bevacizumab for Patients with Ovarian CancerПодробнее

GOG-0218: which patients with ovarian cancer experience highest benefit from 1L bevacizumab?Подробнее

Dr. Jason A. Konner on Bevacizumab in Advanced Ovarian CancerПодробнее

Dr. Hoff on Effect of Ziv-Aflibercept in the Bevacizumab Pre-Treated Subgroup in VELOURПодробнее

Global drug pricing: How cost-effective is bevacizumab?Подробнее

Tanios Bekaii-Saab, MD: Bevacizumab Side-EffectsПодробнее

How Avastin (Bevacizumab) Targeted Therapy Treats Advanced CancerПодробнее

Dr. Rugo on the Efficacy of Bevacizumab in Breast CancerПодробнее

Dr. Tripathy Discusses the AVEREL Bevacizumab Trial ResultsПодробнее

What is the Role of Bevacizumab in Stage IV NSCLC?Подробнее

Dr. Eric Pujade-Lauraine on the AURELIA Bevacizumab Trial for Platinum-Resistant Ovarian CancerПодробнее

Clinical Trials Exploring Bevacizumab in NSCLCПодробнее

Ahmed Kaseb, MD, considers the effectiveness of bevacizumab + atezolizumab in HCCПодробнее